SCHEMBL24287774

SCHEMBL24287774

CC(C)(C)c1ccccc1Oc1nc2ccccc2nc1N[S+]([O-])c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 19/20 0.40
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287510 0.84 ALDH1A1 (0.39) TP53
SCHEMBL24287535 0.75 P2RY1 (0.40) P2RY1TP53MAPT
SCHEMBL24287256 0.74 L3MBTL1 (0.45) P2RY1TP53MAPT
SCHEMBL29516261 0.73 KDM4E (0.60) P2RY1MAPT
SCHEMBL24287534 0.73 KDM4E (0.60) P2RY1MAPT
SCHEMBL24287526 0.68 MAPT (0.39) MAPT
SCHEMBL26813109 0.68 MAPT (0.40) P2RY1TP53MAPT
SCHEMBL127278 0.65 ALDH1A1 (0.48) P2RY1TP53MAPT
SCHEMBL30500977 0.65 ALDH1A1 (0.48) P2RY1TP53MAPT
SCHEMBL13818364 0.63 P2RY1 (0.57) P2RY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback